IL22 and carcinoma: Interestingly, an inhibition in early carcinoma or malignant transition stage (10 weeks) was observed in IL‐22−/−/PyMT tumors as epithelial cells were still confined by basement membrane, which is depicted by positive staining of basement membrane marker laminin‐α1 (Fig. 2A,D).